Predictive Classification of IBS-subtype: Performance of a 250-gene RNA expression panel vs. Complete Blood Count (CBC) profiles under a Random Forest model.
Robinson, J.
Show abstract
In this experiment, an R-script was developed to select the best performing machine learning (ML) predictive classification algorithm for IBS-subtype, and compare the performance of two datasets from the same clinical cohort - 1) The Complete Blood Count (CBC) results, and 2) A 250-gene Nanostring expression panel run on RNA from the "Buffy Coat" fraction. This publicly available data was compiled from open-source repositories and previously published supplementary data. Column labels were reformatted according to "tidy-data" standards. NA values in the data were imputed based on the mean value of the data column. Subject groups included Control (ie. healthy), IBS-D (diarrhea predominant), and IBS-C (constipation predominant) subtypes. These groups had unequal numbers in the original study, and so random re-sampling was used to make the group numbers equal for downstream linear regression-based analyses. The data was randomly split into training and validation subsets, and 5 classification algorithms were tested. Random Forest was clearly the best performing algorithm for both CBC and gene expression panel data, generally with >95% predictive accuracy, without additional tuning. The 250-gene RNA expression panel performed somewhat better than the CBC profile under a Random Forest model, however the CBC profiles had only 13 predictor variables vs. the 250 of the RNA expression panel. Some artifacts may result from the duplication of IBS-D and IBS-C rows from to the group-size balancing method, and so larger and more comprehensive datasets will be obtained for a follow-up analysis. The R-script and reformatted data are published as supplementary material here, and as a component of the AnalyzeBloodworkv1.2 GitHub repository.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Benchmarking software tools for trimming adapters and merging next-generation sequencing data for ancient DNA 90%
- Predicting GD2 expression across cancer types by the integration of pathway topology and transcriptome data 90%
- The META tool optimizes metagenomic analyses across sequencing platforms and classifiers. 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.